STOCK TITAN

Oculis Publishes Notification of Transactions by Person Discharging Managerial Responsibilities

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Oculis (NASDAQ:OCS) has announced that a Person Discharging Managerial Responsibilities (PDMR) has executed trades in accordance with a pre-established Rule 10b5-1 trading plan. The transactions were conducted under the Securities Exchange Act of 1934 guidelines, demonstrating compliance with regulatory requirements for insider trading.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – OCS

-0.51%
1 alert
-0.51% News Effect

On the day this news was published, OCS declined 0.51%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

ZUG, Switzerland, Sept. 26, 2025 (GLOBE NEWSWIRE) -- The attached notification relates to trades entered into by a PDMR of the Company pursuant to a 10b5-1 trading plan, in accordance with Rule 10b5-1(c)(1) of the Securities Exchange Act of 1934, as amended.

Attachment


FAQ

What type of transaction did Oculis (OCS) announce on September 26, 2025?

Oculis announced trades executed by a PDMR (Person Discharging Managerial Responsibilities) under a pre-established Rule 10b5-1 trading plan.

What is a Rule 10b5-1 trading plan for Oculis stock?

A Rule 10b5-1 trading plan is a pre-arranged trading schedule that allows company insiders to trade company stock according to predetermined parameters while complying with insider trading regulations.

Why do Oculis executives use 10b5-1 trading plans?

Executives use these plans to trade company shares in a compliant manner while avoiding accusations of insider trading, as trades are scheduled in advance when they don't possess material non-public information.

How does Oculis ensure compliance with insider trading regulations?

Oculis ensures compliance by having insiders execute trades through pre-established 10b5-1 trading plans in accordance with the Securities Exchange Act of 1934 requirements.
Oculis Holding

NASDAQ:OCS

OCS Rankings

OCS Latest News

OCS Latest SEC Filings

OCS Stock Data

1.71B
50.32M
Biotechnology
Healthcare
Link
Switzerland
Zug